A leading diagnostic organisation focused on a specific variant of Ciz1 as a biomarker for the early detection and management of lung cancer.
- Investment status Realised
- Invested 2011
- Category Health & Life Sciences
A leading diagnostic organisation focused on a specific variant of Ciz1 as a biomarker for the early detection and management of lung cancer.